Sarcopenia, the progressive and generalized loss of skeletal muscle mass and strength/function associated with aging, increases the risk of a vast array of adverse health outcomes, including falls, morbidity, loss of independence, disability, and mortality. As such, sarcopenia poses a huge socioeconomic burden in developed countries. The development and implementation of effective interventions against sarcopenia are therefore a public health priority. A preliminary, fundamental step in such a process entails the agreement of researchers, healthcare professionals and policy-makers around a unique operational definition of sarcopenia. This will facilitate the framing of a clear clinical entity to be incorporated in standard practice, the understanding of the underlying pathophysiology, and the identification of biological targets for drug development.

Landi, F., Calvani, R., Cesari, M., Tosato, M., Martone, A. M., Ortolani, E., Savera, G., Salini, S., Sisto, A., Picca, A., Marzetti, E., Sarcopenia: An overview on current definitions, diagnosis and treatment, <<CURRENT PROTEIN & PEPTIDE SCIENCE>>, 2018; 19 (7): 633-638. [doi:10.2174/1389203718666170607113459] [https://hdl.handle.net/10807/220508]

Sarcopenia: An overview on current definitions, diagnosis and treatment

Landi, Francesco;Calvani, Riccardo;Tosato, Matteo;Martone, Anna Maria;Savera, Giulia;Marzetti, Emanuele
2018

Abstract

Sarcopenia, the progressive and generalized loss of skeletal muscle mass and strength/function associated with aging, increases the risk of a vast array of adverse health outcomes, including falls, morbidity, loss of independence, disability, and mortality. As such, sarcopenia poses a huge socioeconomic burden in developed countries. The development and implementation of effective interventions against sarcopenia are therefore a public health priority. A preliminary, fundamental step in such a process entails the agreement of researchers, healthcare professionals and policy-makers around a unique operational definition of sarcopenia. This will facilitate the framing of a clear clinical entity to be incorporated in standard practice, the understanding of the underlying pathophysiology, and the identification of biological targets for drug development.
2018
Inglese
Landi, F., Calvani, R., Cesari, M., Tosato, M., Martone, A. M., Ortolani, E., Savera, G., Salini, S., Sisto, A., Picca, A., Marzetti, E., Sarcopenia: An overview on current definitions, diagnosis and treatment, <<CURRENT PROTEIN & PEPTIDE SCIENCE>>, 2018; 19 (7): 633-638. [doi:10.2174/1389203718666170607113459] [https://hdl.handle.net/10807/220508]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/220508
Citazioni
  • ???jsp.display-item.citation.pmc??? 52
  • Scopus 102
  • ???jsp.display-item.citation.isi??? 93
social impact